Project Details
| Acronym | EAACI-TNFR2 |
|---|---|
| Status | Finished |
| Effective start/end date | 1/10/22 → 31/03/23 |
Funding
- European Academy of Allergy and Clinical Immunology (EAACI): €12,500.00
Use of TNFR2 agonist antibody to enhance potent regulatory T cells in allergen-specific immunotherapy
- Bazon, Murilo (PI)
- Ollert, Markus (Scientific Advisor/Mentor)